Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the REGAIN open-label extension study
- Hiroyuki Murai
- , Akiyuki Uzawa
- , Yasushi Suzuki
- , Tomihiro Imai
- , Hirokazu Shiraishi
- , Hidekazu Suzuki
- , Meinoshin Okumura
- , Fanny O'Brien
- , Jing-Jing Wang
- , Kenji P Fujita
- , Kimiaki Utsugisawa
- , REGAIN Study Group
- , John Vissing (Medlem af forfattergruppering)
22
Citationer
(Scopus)